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lha nood tor cllnical lrlnls wllh ontioxldflnla according lo Iho Hp pnonatypo 01 
Iha pallonls. 
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Bn&kgr~~mff: lwl~tnnon 1~ RG~RI~~ prolain 6 (APCI which rnaulla Imm 
varloua tactara, lncludtng n mutallon In lha gana for fiaagulanl lnclor V (FV), 
hns bean dnmanslrnlad na A rtak tnclor tar vanoun lhmmbaale. Maraovar, 
lnhntltod lacfar V mln.aanna point mutnllon, FV Q!XIO haa racontly baan 
tdantltlad aa a mn\or QGUR~ ot fnmlllnl vanoua thromboslrr: but thorn la tlttla 
lnlonnnllon about lhalr aaaacmllan wllh artsrlnl thramhosls Thea nludy wns 
doslgnod lo Invaallgala both. raapanaa lo APC nnd Iha factor V mulnllan 
Irlcldanco In Qrenk pnllanlw (plo) wllh a hlslary al naula myoonrdlnl tnlamllon 
(astabllahad oriarlnl lhrombaala) nnd pta with aRAart\II\\ hypartondon. a lqh 
rlak group tar nnarlnl Ihmmboals. 
M@lhc&?: 4R pla with a hlnlary al myo%?rdtnl inlmclton (Rrairp A), 80 
pI8 wlh a hlalory ot QRsOnltal hyparlunalan (Graup 8) and 62 flga-matchad 
control8 wllhaul nrtorlnl dlaanao (Group C) warn shldmd, Pnlionte usmg 
anllcongulnnl drugs WOM ox&dad. Rnspanno la APC wnfl dotorminod in 
daubla conlrttugod plnlalal poor plnsma. Pnllonla waro gonatypo tar Iho Arg 
506 to Qln mutallon m lha nana for cangulnnt fnotor V, 
F!&+%JII?J: The lncldenca al lhn mulollon wna XI%, 13.75% and 6% in lho 
@nupa A, R nnd C mspocllvaly. l’ho lncldonco al rmiucod mnpanao lo APC 
was 47.5% In group A vs 13% In ~mup C (p . O,gOr) nnd 36.25% In group R 
VR 13% In amup C (O.OQl . p .. O.Ot). Tho ruaponsn to nctlvated pmtain C 
(APC) expmanad ns mann vnkio i SD was 2.05 -I, 0.36 In group A vs 2.56 t 
0.49 in group C (p . 0.001) nnd 2 .I 0.18 In gmup B VR 2.58 I 0.40 In group 
c (p i aoar). 
Conckislon: Qur hndngs sugqast thnt Gmok pntlonts with R history al 
acute myo-znrdlnl lnlnml~on or ossonllnl hyporlonalon hnva n slgmlicanlly 
lncmnsod lncldonco ol both mducod msponso lo APC and lnhonlod laclor V 
mUnllon In compnnson lo Iho canlrol graup. Thoso prellmlnnry rusults rniso 
lho posalblllty Ihnl mducod msponso la APC mny bo n rlak tactor tar artonr~~ 
dlsonsa. 
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Coronary Artery Ulsease 
M Shochlor. C N 0 Morz. M Paul-Labrador, M.D. Mo\loy, 0 Corcoh. 
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Elovatod plasmn npokpoproloin (ape).R leval is n known nsk Ior atheroscta- 
rotlc CAD, howavor Its mlatlonshlp to anorial thromhosm ts unknown. We 
prospoctlvoly nssessod npo-Et and platelet-dapondonl thrombosis (PDT) in 
42 stablo CAD pattents on flsplnn and Ilpld.loworing therapy. by exposing 
porcine aorl~c media lo tholr llowtng nonanllcunguleted venous blood for 5 
mhutos at a shonr rata ot 600 sot ’ a1 37% using an ex-vivo flow cham- 
hor model Tho PDT was measured by computerized morphomotry and 
oxprossod as ,rrn:/mm of tho aomc surface 
&?slrlls: PDT was s~gnillcantly correlated wilh apo.R (Figure). PDT did 
nol cOrreQIo wrlh sorum Idal cholesterol (171 .I 26 mgldL. r = 0.3). CDL-C 
(102 t 26 mg/dL. r = 0.2). HDL-C (41 t 10 mg/dL. I = 0.1). apo A-l (126 
t 16 mg/dL, r = 0.1) or fibnnogen levels (296 f 60 mgidL. r = 0.1) (values 
are maan t SO: all p = NS) 
Concfus~on: Elevated apo-Et levels are associated with augmen~sd PDT 
in stable CAD patients despite controlled lipid levels. These findings suggest 
!hat the positive relarionship of eleva&d apo8 lo CAD may be, in part. related 
lo IIS prolhrombotlc effects 
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Fibrlnogan and C-roackva prutaln (CRP), 2 Inflammatory mnrksn that pmdtct 
cardtovaecular dtrroasa, may bs uaalul In assenaln~ shangt3s in risk. To 
determlns varlabltlty and asaoclattons avar ilma, we measured fibrinogen 
(Clausa method) and CRP (ELlSA) In 100 sub]acls (50 men. 60 women) 
tram Iha FramIngham OHsprtng Study OvQr I +yaar Interval (ago at btialtns 
wns 64 c 10 yanra). Tham wna n clean carmlatien between ba8altne and 
lallaw=up I~als (1~ figure), Enaallna LbrtnaQen G!l2 -t 8s mgfdl) incresaed 
by 6% (p 3 0,087) nnct CRP (X82 % 331 m@l) by 6% (R J NS). Them was 
nlaa a eigntftsnnt correlation batwaon bbnnogon and CRP both at baserma 
(R 9 0.6% p ‘: O.pOl) and tollow.up (R 6” 0.87, p i %aOl), supporllng a bnh 
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Doapilo Doing acute phase ranclanls. bolh libnnogen and CRP were rel- 
ntivaly stablo over lho 4.yoar pmtod. suggesling Ihat longiludinal ctlttorcms 
may provide inslght mlo changing cnrdtovascular risk. 
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6ackgmund: We have previously rcponcd the prevalence of chlamydlal anti- 
gen m coronary atheromas lrom symplomallc pts undergolng dm?ctlonal 
alherectomy and m control pts. In thal sludy. we used a genus.specillc an- 
tlbody (G-ab) recognizmg a chlamydral lipopolysamhande on trozen Ussue 
samples by ~mmunocytochem~stry 
A$e?bo&: We sought to extend and compare our observattons by retestmg 
those alheroma and control samples for the presence of a specros~specdic (C 
pneumomae. RR 402) antIbody (S-ab). We used frozen lissue samples and 
a slandard immunocytochemical approach (indirect immunolluorescence). 
Results: We found 911114 (79.6%) athereclomy samples from CAD pa 
tlonts were posItwe wllh G-ab and 25/47 (63.2%) were positive ~vllh S-ab 
Kappa slnlislic lor the relation between the staining resul1 seen wvilh lhese 
antibodies was 0.047. showing only marginal agreement. Conlml tissue from 
cornnary artenes of pallents dying of traumatic causes wilhoul alhemsclero- 
SIS was porllive m 0121 wllh G-ab and 2/21 (9.5ob) wllh S-ab. Patlents with 
Imnsplant-rc’sttct coronary disease had O/12 samples positwe wllh G-ab and 
l/12 (6%) with S-ab. However. the dltterences between immunoposilivily m 
atheroma versus control samples were significant for both G-ab (p = 0.001) 
and S-ab (p = 0.01) Two of three batches of S-ab caused unacceptably high 
levels of background statmng. 
Conclusions: Chlamydlal antigen prevalences detected by either G.ab 
or S-ab immunocytochemistry are Increased in coronary alheroma samples 
compared to controls. SensitivQ and reliability at G-ab IS higher, kkety due 
lo the lower avtdity 01 S-ab lo chlamydial anllgens and higher background 
starwg. The posstbibty of > 1 chlamydral specfes betng involved in athero- 
sclerosis cannot be excluded. 
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Background: Studies have suggested inlriguingly that Chlamydia Pneumo- 
